Business
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2024 Financial Results
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2024 Financial Results ...
About this update from Medipharm Labs Corp.
[{"type":"text","content":"\n\n\n\n MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2024 Financial Results\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n\n TORONTO\n \n\n ,\n \n\n March 26, 2025\n \n\n /CNW/ -\n \n MediPharm Labs Corp.\n \n (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (\"MediPharm\", \"MediPharm Labs\" or the \"Company\") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its full year and fourth quarter financial results for the three and twelve months ended December 31\n \n st\n \n , 2024, before markets open on Monday, March 31\n \n st\n \n , 2025.\n \n\n\n\n\n\n\n\n\n An updated company presentation including select highlights from the period ended December 31\n \n st\n \n , 2024 will be available on MediPharm's website following the earnings release, this in lieu of a quarterly earnings call hosted by management.\n \n\n\n About MediPharm Labs\n \n\n\n Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities for delivery of pure, trusted and precision-dosed cannabis products for its customers. MediPharm Labs develops, formulates, processes, packages and distributes cannabis and advanced cannabinoid-based products to domestic and international medical markets.\n \n\n In 2021, MediPharm Labs received a Pharmaceutical Drug Establishment License from Health Canada, becoming the only company in North America to hold a commercial-scale domestic Good Manufacturing Practices License for the extraction of multiple natural cannabinoids. This GMP license was the first step in the Company's current foreign drug manufacturing site registration wi...